FDA Releases Compounding Policy Priorities

Drug Industry Daily
A A
The FDA issued a compounding policy priorities plan for 2018, highlighting manufacturing standards for outsourcing facilities and collaboration with state regulators.

To View This Article:

Login

Subscribe To Drug Industry Daily